Director/PDMR Shareholding
Source: RNS
28 December 2022
Pod Point Group Holdings plc
(the "Company" or "Pod Point")
NOTIFICATION OF TRANSACTIONS BY PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR')
The Company announces that it has issued 70,187 ordinary shares of £0.001 each in the Company ("Ordinary Shares") to satisfy the exercise of nil-cost options under the Pod Point IPO Share Plan by David Surtees, a Director and PDMR of the Company as detailed below.
On completion of the exercise of the options, Mr Surtees has retained ownership of his newly issued Ordinary Shares.
Following the issue of the new Ordinary Shares, the number of Ordinary Shares in issue has increased to 154,025,118 with each share carrying a right to vote. The Company has no shares in treasury.
Enquiries
Tulchan Communications |
+44 207 353 4200 PodPoint@tulchangroup.com |
James Macey White, Mark Burgess, Matt Low, Laura Marshall, Arthur Rogers |
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a) |
Name |
David Surtees |
||||
2. |
Reason for notification |
|||||
a) |
Position / status |
Director / PDMR - Chief Financial Officer |
||||
b) |
Initial notification / amendment |
Initial notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Pod Point Group Holdings plc |
||||
b) |
LEI |
213800MY9U5MEDG21D89 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; |
|||||
a) |
Description of the financial instrument |
Ordinary shares of £0.001 each ISIN: GB00BNDRD100 |
||||
b) |
Nature of the transaction |
Exercise of Nil Cost Option |
||||
c) |
Price(s) and volume(s)
|
|
||||
d) |
Aggregated information
Aggregated volume
Price |
N/A
|
||||
e) |
Date of the transaction |
2022-12-23
|
||||
f) |
Place of the transaction |
Outside of a trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.